Related Experiment Video
Updated: Feb 7, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
Multidrug-resistant Pseudomonas aeruginosa infections: current status, challenges, and prospects of phage therapy
Bo Yan1,2, Can Yan1,2, Yafang Ding1,2
1Affiliated Hospital of Jinggangshan University, Ji'an, China.
Abstract:
The emergence of drug-resistant bacterial infections has profoundly impacted global public health. Key pathogens include multidrug-resistant Pseudomonas aeruginosa (MDR-PA), MDR Acinetobacter baumannii, and methicillin-resistant Staphylococcus aureus. Among these pathogens, MDR-PA carries numerous virulence factors that induce extensive tissue destruction. Its inherent ability to form biofilms promotes chronic infection persistence and multidrug resistance, leading to mortality rates up to 40%. Currently, antibiotics remain the mainstay for the treatment of MDR-PA infections. Nevertheless, the escalating prevalence of drug resistance has rendered conventional antibiotic regimens increasingly recalcitrant. Consequently, the imperative for innovative antimicrobial therapeutic modalities to combat Pseudomonas aeruginosa has intensified in the realm of public health. In this context, phage therapy, with its precise bactericidal activity and high host biosafety, has emerged as a compelling alternative. This review provides a comprehensive synthesis of recent advancements in phage therapy targeting MDR-PA, covering clinical applications, current therapeutic approaches, and emerging technological platforms. It further dissects the resistance mechanisms encountered during treatment and puts forward novel counterstrategies to address antimicrobial resistance challenges-including optimized phage-antibiotic synergy, phage genome engineering, and dynamic adaptive therapeutic frameworks-aimed at advancing clinical translation.
Insights
Phage therapy offers a promising alternative to antibiotics for treating multidrug-resistant Pseudomonas aeruginosa infections. This approach utilizes bacteriophages to combat resistant bacteria, addressing a critical public health challenge.
Area of Science:
- Microbiology
- Infectious Diseases
- Biotechnology
Background:
- Multidrug-resistant bacterial infections, particularly from Pseudomonas aeruginosa (MDR-PA), pose a significant global health threat.
- MDR-PA infections are associated with high mortality rates (up to 40%) due to virulence factors and biofilm formation.
- Conventional antibiotic treatments are becoming less effective against MDR-PA, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review recent advancements in phage therapy for multidrug-resistant Pseudomonas aeruginosa.
- To synthesize current clinical applications, therapeutic approaches, and emerging technologies in phage therapy.
- To explore resistance mechanisms and propose counterstrategies for effective phage therapy.
Main Methods:
- Comprehensive literature review of recent studies on phage therapy against MDR-PA.
- Analysis of clinical applications, therapeutic strategies, and technological platforms.
- Examination of bacterial resistance mechanisms and development of novel counterstrategies.
Main Results:
- Phage therapy demonstrates precise bactericidal activity and high host biosafety as an alternative to antibiotics.
- Recent advancements include optimized phage-antibiotic synergy, phage genome engineering, and adaptive therapeutic frameworks.
- Understanding resistance mechanisms is crucial for developing effective counterstrategies.
Conclusions:
- Phage therapy is a viable and evolving alternative for combating multidrug-resistant Pseudomonas aeruginosa infections.
- Innovative strategies like phage-antibiotic synergy and genome engineering are key to overcoming resistance.
- Further research and development are essential for the clinical translation of phage therapy.
Related Concept Videos
Marcia's Theory of Identity Status
Resistivity
Resistance
Gene Therapy
Electrical Current
Equivalent Resistance

